Lower back surgery represents a life-changing decision that demands careful consideration. While many view surgery as a ...

H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on FibroBiologics, Inc. (FBLG – Research Report) today and set a price ...

The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face ...

BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) announced the company’s 3Q 2024 financial results and while a company at this stage is far more reliant on testing of products, ...

For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...

Nov. 15, 2024 — More time spent sitting, reclining or lying down during the day may increase the risk of cardiovascular disease (CVD) and death, according to a new study. More than roughly 10 ...

Management typically involves medications that modify the immune system, but natural treatments may also help reduce symptoms. Lupus is an autoimmune condition. It develops when the immune system ...

The high-quality studies showed that thermal RFA of the DRG is not effective in the treatment of chronic lumbar radicular pain. The trial results provided inconclusive evidence of the efficacy of ...

can limit symptom relapses and slow the progression of the disease. Other medications are used to address specific symptoms. Talk with your healthcare provider about the ways that natural techniques ...

Satellos’ condensed consolidated interim financial statements for the three and nine months ended September 30, 2024, and the related management’s discussion and analysis (MD&A) will be available on ...

Trump’s pick to lead the Department of Health and Human Services, has for years called attention to what he considers an “epidemic” of chronic disease that has left America’s children ...